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Abstract 
Patient data management systems are becoming commonplace in the ICU. While their intent is to automate patient 
charting, they provide a readily accessible, large database that would be potentially useful for clinical research and 
quality improvement projects. We sought to determine if patient data management information could be of value 
describing neonatal oxygenation saturation exposure (percent time in oxemic-ranges). Our primary measure was the 
accuracy of 60-second sampling over a 24-hour period, as compared to previously reported results in 23 infants. We 
found this to be highly accurate. We also conducted a sensitivity analysis using 3 other sampling rates (20, 30, 120 
seconds) and 3 other time epochs (4, 12 and 48 hours). We found that sampling frequency and time epoch length impacted 
accuracy. Nevertheless these combinations could all be useful, if limitations are taken into account in the analysis design. 
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Background 
Patient data management systems (PDMS) are 
becoming commonplace in large medical centers. They 
integrate ongoing vital sign status from patient monitors 
with lab results and details of important therapeutic 
interventions such as infusion and respiratory support. 
Their primary aim is to provide accurate automated 
patient charting for medical records. However they  
also provide a database potentially useful for quality 
improvement and clinical research projects. 
Oxygenation saturation exposure has been shown to 
dramatically impact outcomes in the neonatal ICU [1]. 
Most baseline validation studies of neonatal SpO2 
control have collected data every 5 seconds [2]. On the 
other hand, PDMS collection of data for patient charting 
varies but is often every 60 seconds. Nevertheless, such 
PDMS data have been used to evaluate the impact of 
changes in practice on neonatal oxygenation in the ICU 
[3–5]. 
The theoretical impact of sampling rate can be deter-
mined mathematically, but is only precise for periodic 
patterns that are also uniform over the time epoch. Most 
physiological variables do not meet these criteria; 
certainly not the SpO2 levels of acutely ill neonates. One 
study did determine the impact of SpO2 averaging time 
on characterization of individual desaturation episodes 
[6], but we are unaware of any studies evaluating the 
impact of sampling rate on the accuracy of aggregated 
oxygen saturation exposure. 
We have access to a database of SpO2 data collected 
every 5 seconds from published evaluations of 
FiO2-SpO2 automated control systems in the NICU. Our 
aim in this investigation was to determine the impact of 
sampling rate on the accuracy of oxygenation exposure 
to provide guidance on the limitations of using PDMS 
data for Quality Improvement and research projects. 
Methods 
We selected 23 typical cases from two neonatal 
studies in our database [7, 8]. Each included 48 hours of 
data with SpO2 collected every 5 seconds. Care was 
taken to include a wide range of infant-stabilities based 
on percent time in the SpO2 normal range. 
We hypothesized that sufficient accuracy would be 
achieved with a 60 second sample rate for an obser-
vation epoch of 24 hours. In light of the differences 
reported in various SpO2 control studies, and the accu-
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racy of SpO2 measurement [9], we assumed an accuracy 
of 1 %-time would be acceptable. For purposes of evalu-
ating sensitivity, we also considered faster and slower 
sample rates as well as shorter and longer time epochs. 
Rather than evaluating the accuracy across the entire 
range we selected 3 specific clinically relevant end-
points, %-time in hypoxemia, normoxemia and 
hyperoxemia. These oxemic-ranges were defined as 
SpO2: ≤80%, 87–96% and 98–100%, respectively. We 
sampled the SpO2 data at precise intervals of 20, 30, 60 
and 120 seconds. We also evaluated SpO2 monitoring 
epochs of 4, 12, 24 and 48 hours. We calculated the 
%-time for each of the three oxemic ranges for each of 
the conditions. For each we determined the difference in 
%-time as compared to the 5-second data. 
Precision was defined as the absolute value of the 
differences, and bias as the mean of the differences. In 
total there were 16 cases (each of the 4 evaluation time 
epochs, each of the 4 sampling rates). We chose to 
define accuracy as the square root of the sum of the 
mean of the squares of precision and bias. We also 
calculated the 95% confidence limits of each summary 
mean, based on the variation between subjects to 
provide a measure of uncertainty. Accuracy, bias and 
precision were all presented as absolute %-time units, 
not as percent of reading. 
Data was sampled and summarized using MatLab 
(vR2015a, MathWorks). The data were tabulated, 
charted and analyzed using Excel (v14.7.2, Microsoft) 
and XLSTAT (v19.02, Addinsoft). For purposes of 
comparison, measurements were considered statistically 
significantly different if the 95% confidence limits did 
not overlap. 
Results 
A histogram of the aggregate SpO2 exposure for the 
23 subjects is shown in Figure 1. The median and range 
of the %-time in the 3 oxemic-ranges for these subjects 
were: hypoxemia (4.0%, 0.6%–9.7%), normoxemia 
(62%, 41%–93%) and hyperoxemia (5.3%, 0.1%–27%). 
The precision, bias and accuracy of the primary 
parameters (sample rate of 60 seconds and epoch length 
of 24 hours) are shown in Table 1a. The accuracy in all 
3 oxemic-ranges is excellent: (hypoxemia 0.4 %-time, 
normoxemia 1.0 %-time and hyperoxemia 0.3 %-time). 
The accuracy of normoxemia was statistically signify-
cantly larger than the hypoxemia and hyperoxemia 
accuracy. Not different among the oxemic-ranges, the 
bias was also minimal as shown.  Thus the accuracy was 
primarily impacted by the precision, and not a system-
atic sampling bias. 
The accuracy for the 60-second sampling rate for the 
3 other epochs (4, 12, 48 hours) is shown in Table 1b. 
As would be expected the data show a trend of the 
accuracy decreasing as the epoch is shortened. Illustra-
tive of this, for normoxemia the accuracy ranges 
between 0.8% for 48-hour epoch and 2.9% for a 4-hour 
epoch. 
 
 
Fig. 1: Histogram of SpO2 Exposure. Solid line 
represents all subjects.  Dotted line the 7 subjects with 
the most time in normoxemia, and diamonds the 
6 subjects with the least time in normoxemia. 
 
Table 1a: Precision, Bias and Accuracy for 60-second. 
Sampling and 24-hour Epoch [mean (95% CI)]. 
 Precision Bias Accuracy 
Hypoxemia 0.3 %-time (0.2–0.4) 
0.1 %-time 
(0–0.3) 
0.4 %-time 
(0.3–0.6) 
Normoxemia 0.7 %-time (0.5–1.0) 
0 %-time 
(-0.4–0.4) 
1.0 %-time 
(0.7–1.4) 
Hyperoxemia 0.3 %-time (0.1–0.3) 
0 %-time 
(-0.2–0.1) 
0.3 %-time 
(0.1–0.5) 
 
Table 1b: Accuracy for 60-second. Sampling for 
48-hour, 12-hour and 4-hour Epochs [mean (95% CI)]. 
 Accuracy 48 hours 
Accuracy 
24 hours 
Accuracy 
12 hours 
Hypoxemia 0.3 %-time (0.2–0.4) 
0.7 %-time 
(0.4–1.0) 
1.1 %-time 
(0.6–1.6) 
Normoxemia 0.8 %-time (0.5–1.1) 
1.5 %-time 
(1.0–2.0) 
2.9 %-time 
(1.9–4.0) 
Hyperoxemia 0.2 %-time (0.1–0.3) 
0.5 %-time 
(0.2–0.7) 
0.9 %-time 
(0.5–1.2) 
Hypoxemia ≤80% SpO2, normoxemia 87–96% SpO2 and 
hyperoxemia 98–100% SpO2 (95% Confidence 
Interval). 
 
Figure 2abc show the accuracy of %-time, with 95% 
confidence limits, for all 16 combinations of sampling 
rate and epoch length. The accuracy tends to improve 
proportionately with an increase in sampling rate. As an 
example, for the 4-hour epoch, the accuracy of 
normoxemia is 3.8 %-time for 120-second sampling 
rate, 2.9 %-time for 60-second sampling, 1.5 %-time for 
a 30-second sampling and 0.8 %-time for a 20-second 
sampling (Figure 2b). 
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Fig. 2abc: Accuracy for different Sampling Rates and 
Epochs. Whiskers reflect 95% CL of the mean. 
 
Though evident in Figures 2abc, as detailed in 
Table 2, even the 120-second sampling rate is suitable 
(approximately 1% accuracy) for assessing longer time 
epochs. 
 
 
Table 2: Accuracy for 120-second Sampling with 
48-hour, 24-hour and 12-hour Epochs. 
 Accuracy 48 hours 
Accuracy 
24 hours 
Accuracy 
12 hours 
Hypoxemia 0.4 %-time (0.2–0.6) 
0.6 %-time 
(0.4–0.8) 
0.9 %-time 
(0.6–1.3) 
Normoxemia 1.2 %-time (0.6–1.7) 
1.5 %-time 
(1.0–2.0) 
2.4 %-time 
(1.5–3.3) 
Hyperoxemia 0.4 %-time (0.3–0.6) 
0.6 %-time 
(0.3–0.9) 
0.8 %-time 
(0.5–1.1) 
Hypoxemia ≤80% SpO2, normoxemia 87–96% SpO2 and 
hyperoxemia 98–100% SpO2 (95% Confidence 
Interval). 
Discussion 
We evaluated the impact on the accuracy of %-time in 
clinically relevant oxemic ranges associated with 
changes in sampling rate and also duration of endpoint 
epoch. We confirmed our hypothesis that 60 second 
sampling was accurate. We found different sampling 
rates suitable for many uses, but identified some 
limitations. Two anticipated trends were apparent. For 
each of the three-oxemia categories the accuracy was 
worse with both slower sampling rates and shorter 
epochs. We also found the accuracy was different for 
three oxemic-ranges. 
We speculated that the impact of the sampling rate on 
accuracy might differ with different oxemic endpoints. 
Hypoxemia exposure is characterized by precipitous 
desaturations of varying lengths followed by quick 
recovery associated with an intervention or recovery 
from disordered breathing. In contrast hyperoxemic 
exposure is usually caused by failure to wean inspired 
oxygen with episodes perhaps less precipitous and of 
longer duration. Finally we would expect that periods of 
normoxemia would be characterized by longer duration. 
There was a trend for the accuracy for hyperoxemia to 
be slightly better than during hypoxemia, but the 
difference is small and certainly not relevant. In contrast 
the accuracy during normoxemia was markedly worse 
than either. We note, however, that the median values 
for the three exposure endpoints were 5 %-time 
(hyperoxemia), 4 %-time (hypoxemia) and 63 %-time 
(normoxemia). Considering the difference in scale, the 
accuracy as a percent of reading was actually much 
better during normoxemia, so that these relative 
differences in absolute accuracy are probably not 
relevant. 
We offer several sources of data suggesting 
anticipated differences in SpO2 that might be expected 
in research or quality improvement. A meta analysis of 
10 studies comparing automated to manual control of 
FiO2 reported an aggregate difference in the percent  
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time in the intended SpO2 range of 12 %-time (range 
among studies 4–35) and in severe hypoxemia of 
1 %-time (range among studies (less tha1–2)) [2]. One 
center published the results of three changes in practice 
[3–5]. They reported differences in the percent time in 
the intended SpO2 range between 12–14 %-time, in 
severe hypoxemia between less than 1–3 %-time and in 
hyperoxemia between 3–8 %-time. Finally several 
studies have reported the difference in the percent time 
in the intended SpO2 range among automated control 
with different settings of 0–2 %-time [8, 10–11]. These 
provide a reasonable perspective of what size changes 
might be expected with a change in practice. 
Unfortunately an understanding of what magnitude of 
change in exposure to SpO2 extremes might effect 
clinical outcomes is very limited. In a landmark trial  
of high and lowered SpO2 targets an increase in 
hyperoxemia from less than 10 to 25 %-time was 
associated with an increase in severe pulmonary and 
retinal morbidity [12]. A recent analysis of the impact of 
exposure to severe hypoxemia in a large group of 
extremely preterm infants reported an increase in late 
death or disability associated with increasing percent 
time with SpO2 less than 80%. They found a decrease in 
this composite outcome of nearly 50% associated with 
an decrease of exposure from more than 10 to less than 
1 %-time [13]. These provide a range of change of 
exposure to SpO2 extremes associated with significant 
changes in outcome. Smaller incremental changes might 
reasonably be expected to be associated with smaller 
incremental changes in outcome that would be relevant. 
We suggest that a 2 %-time change might be clinically 
relevant for hypoxemia, and something larger for 
hyperoxemia. 
In the prospective planning of an analysis of 
oxygenation exposure using PDMS data one must 
consider the measurement variability as well as the 
desired detectable clinically relevant change in order to 
determine the necessary sample size (i.e., number of 
subjects). As an illustration, consider comparing the 
exposure to hypoxemia between the morning and 
evening 12-hour shifts. Accepting that a difference of 
2 %-time was clinically relevant, and using the standard 
deviation we found as the variability, we calculated the 
number of subjects needed. Based on a standard power 
calculations, there would be an 80% chance of detecting 
a 2 %-time difference in the time in hypoxemia at the 
p<0.05 level of certainty with a comparison of 27 
subjects with 60-second sampling and 68 subjects with 
120-second sampling. In contrast it would be unreason-
able to expect that an observed 2 %-time difference 
would be reliable when looking at one patient’s 
morning-evening difference in one day. Nevertheless, 
the difference associated with a marked change on 
outcome (e.g., 1 to 10 %-time) would be reliable. 
Our analysis has some limitations. First, while the 
trends among sample rates and epoch lengths that we 
explored in the sensitivity analyses were every 
consistent, only some reached statistical significance. 
Nevertheless this is markedly less than the clinical 
accuracy of the pulse oximeter [9]. Second, while our 
sample of subjects was diverse, the number of subjects 
made it impossible to explore subgroup analyses based 
on the extremes of exposure. Both would require 
analysis of a larger sample of cases. Further other 
metrics of accuracy such as Bland-Altman or regression 
might have provided a different perspective. Finally it 
should also be noted that using data from a PDMS, at 
any nominal sampling frequency, is unable to capture 
the prevalence of infrequent prolonged episodes of 
oxygenation extremes, or swings between extremes that 
might also impact outcome. 
Conclusion 
Our analysis shows that using SpO2 data from 
a PDMS for evaluation of oxygenation exposure with 
a sampling period of 60 seconds is reliable. It also 
suggests that faster sampling rates would permit reliable 
analysis within smaller numbers of subjects or shorter 
exposure periods and that even 120-second sampling 
would be useful for some evaluations. Finally we 
encourage centers with access to this kind of data to use 
it to explore the association of SpO2 extremes with not 
only better care practices but also improved outcomes. 
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